Holdings
NEA Management Company, LLC
As of Jun 30, 2026, NEA Management Company, LLC reported 23 positions worth US$1.51B. Largest: Trevi Therapeutics, Inc., Mbx Biosciences, Inc. and Monte Rosa Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 13.2M | US$247M | no change | Jun 30, 2026 |
| Mbx Biosciences, Inc. | 3.61M | US$200M | no change | Jun 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 7.69M | US$186M | no change | Jun 30, 2026 |
| Celcuity Inc. | 1.71M | US$179M | −575K | Jun 30, 2026 |
| Spyglass Pharma, Inc. | 7.39M | US$165M | no change | Jun 30, 2026 |
| Savara, Inc. | 24.5M | US$151M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 4.02M | US$102M | no change | Jun 30, 2026 |
| Coursera, Inc. | 12.9M | US$72.6M | no change | Jun 30, 2026 |
| Aurinia Pharmaceuticals Inc | 3.97M | US$67.4M | no change | Jun 30, 2026 |
| Oric Pharmaceuticals, Inc. | 4.12M | US$44.6M | no change | Jun 30, 2026 |